60 related articles for article (PubMed ID: 25393795)
1. Assessment of ALK status by FISH on 1000 Spanish non-small cell lung cancer patients.
Vidal J; Clavé S; de Muga S; González I; Pijuan L; Gimeno J; Remón J; Reguart N; Viñolas N; Gironés R; Bernet L; Majem M; Bosch-Barrera J; Porta R; Alonso N; Palmero R; Taus A; Albanell J; Espinet B; Salido M; Arriola E
J Thorac Oncol; 2014 Dec; 9(12):1816-20. PubMed ID: 25393795
[TBL] [Abstract][Full Text] [Related]
2. ALK1 Gene Rearranged Pulmonary Sarcomatoid Carcinoma Masquerading as Tuberculosis in a Young Male.
Sahay A; Kumar R; Janu A; Prabhash K
Turk Patoloji Derg; 2020; 1(1):71-77. PubMed ID: 32149365
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity to ALK-Directed Therapy in Osteosarcoma With an Acquired
Ordulu Z; Giunta P; Hung WT; Hung YP; Simon J; Fintelmann FJ; Lennerz JK; Naxerova K; Cote GM
JCO Precis Oncol; 2023 Sep; 7():e2300287. PubMed ID: 38096470
[No Abstract] [Full Text] [Related]
4. Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-small cell lung cancer: a comparison of Ventana immunohistochemistry and fluorescence in situ hybridization.
Wang W; Tang Y; Li J; Jiang L; Jiang Y; Su X
Cancer Cytopathol; 2015 Feb; 123(2):117-22. PubMed ID: 25529354
[TBL] [Abstract][Full Text] [Related]
5. Future options for ALK-positive non-small cell lung cancer.
Iacono D; Chiari R; Metro G; Bennati C; Bellezza G; Cenci M; Ricciuti B; Sidoni A; Baglivo S; Minotti V; Crinò L
Lung Cancer; 2015 Mar; 87(3):211-9. PubMed ID: 25601484
[TBL] [Abstract][Full Text] [Related]
6. ROS1 immunohistochemistry among major genotypes of non-small-cell lung cancer.
Boyle TA; Masago K; Ellison KE; Yatabe Y; Hirsch FR
Clin Lung Cancer; 2015 Mar; 16(2):106-11. PubMed ID: 25467930
[TBL] [Abstract][Full Text] [Related]
7. Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.
von Laffert M; Warth A; Penzel R; Schirmacher P; Kerr KM; Elmberger G; Schildhaus HU; Büttner R; Lopez-Rios F; Reu S; Kirchner T; Pauwels P; Specht K; Drecoll E; Höfler H; Aust D; Baretton G; Bubendorf L; Stallmann S; Fisseler-Eckhoff A; Soltermann A; Tischler V; Moch H; Penault-Llorca F; Hager H; Schäper F; Lenze D; Hummel M; Dietel M
J Thorac Oncol; 2014 Nov; 9(11):1685-92. PubMed ID: 25436802
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel HIP1-ALK fusion variant in Non-Small-Cell Lung Cancer (NSCLC) and discovery of ALK I1171 (I1171N/S) mutations in two ALK-rearranged NSCLC patients with resistance to Alectinib.
Ou SH; Klempner SJ; Greenbowe JR; Azada M; Schrock AB; Ali SM; Ross JS; Stephens PJ; Miller VA
J Thorac Oncol; 2014 Dec; 9(12):1821-5. PubMed ID: 25393796
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of multiplexed predictive biomarker screening in non-small-cell lung cancer.
Romanus D; Cardarella S; Cutler D; Landrum MB; Lindeman NI; Gazelle GS
J Thorac Oncol; 2015 Apr; 10(4):586-94. PubMed ID: 25590606
[TBL] [Abstract][Full Text] [Related]
10. Automation of ALK gene rearrangement testing with fluorescence in situ hybridization (FISH): a feasibility study.
Zwaenepoel K; Merkle D; Cabillic F; Berg E; Belaud-Rotureau MA; Grazioli V; Herelle O; Hummel M; Le Calve M; Lenze D; Mende S; Pauwels P; Quilichini B; Repetti E
Exp Mol Pathol; 2015 Feb; 98(1):113-8. PubMed ID: 25576649
[TBL] [Abstract][Full Text] [Related]
11. Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry.
Wang J; Shen Q; Shi Q; Yu B; Wang X; Cheng K; Lu G; Zhou X
J Exp Clin Cancer Res; 2014 Dec; 33(1):109. PubMed ID: 25527865
[TBL] [Abstract][Full Text] [Related]
12. Micro-cost Analysis of ALK Rearrangement Testing by FISH to Determine Eligibility for Crizotinib Therapy in NSCLC: Implications for Cost Effectiveness of Testing and Treatment.
Parker D; Belaud-Rotureau MA
Clin Med Insights Oncol; 2014; 8():145-52. PubMed ID: 25520569
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic lymphoma kinase gene analysis as a useful tool for identifying primary unknown metastatic lung adenocarcinoma.
Watanabe N; Ishii T; Takahama T; Tadokoro A; Kanaji N; Dobashi H; Bandoh S
Intern Med; 2014; 53(23):2711-5. PubMed ID: 25447655
[TBL] [Abstract][Full Text] [Related]
14. Non-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset.
Guo Y; Ma J; Lyu X; Liu H; Wei B; Zhao J; Fu S; Ding L; Zhang J
BMC Cancer; 2014 Nov; 14():834. PubMed ID: 25407901
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.
Lin C; Shi X; Yang S; Zhao J; He Q; Jin Y; Yu X
Lung Cancer; 2019 May; 131():62-68. PubMed ID: 31027700
[TBL] [Abstract][Full Text] [Related]
16. Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.
Clavé S; Rodon N; Pijuan L; Díaz O; Lorenzo M; Rocha P; Taus Á; Blanco R; Bosch-Barrera J; Reguart N; de la Torre N; Oliveras G; Espinet B; Bellosillo B; Puig X; Arriola E; Salido M
Clin Lung Cancer; 2019 Jul; 20(4):e421-e429. PubMed ID: 30898567
[TBL] [Abstract][Full Text] [Related]
17. First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
Solomon BJ; Mok T; Kim DW; Wu YL; Nakagawa K; Mekhail T; Felip E; Cappuzzo F; Paolini J; Usari T; Iyer S; Reisman A; Wilner KD; Tursi J; Blackhall F;
N Engl J Med; 2014 Dec; 371(23):2167-77. PubMed ID: 25470694
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive NGS profiling to enable detection of
Clavé S; Jackson JB; Salido M; Kames J; Gerding KMR; Verner EL; Kong EF; Weingartner E; Gibert J; Hardy-Werbin M; Rocha P; Riera X; Torres E; Hernandez J; Cerqueira G; Nichol D; Simmons J; Taus Á; Pijuan L; Bellosillo B; Arriola E
Front Oncol; 2023; 13():1225646. PubMed ID: 37927472
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic Lymphoma Kinase (ALK)-Rearranged Lung Cancer That Showed Exclusively Scattered Isolated Cells Devoid of Mucin Production in Cytology.
Okazaki T; Iwasaki Y; Kubo Y; Kodama K; Nakatsuka SI
Cureus; 2023 Oct; 15(10):e46339. PubMed ID: 37920641
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers.
Arriola E; Bernabé R; Campelo RG; Biscuola M; Enguita AB; López-Ríos F; Martínez R; Mezquita L; Palanca S; Pareja MJ; Zugazagoitia J; Arrabal N; García JF; Carcedo D; de Álava E
JCO Precis Oncol; 2023 Mar; 7():e2200546. PubMed ID: 36862967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
